Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Insights into Neuroinflammation in Parkinson’s Disease: From Biomarkers to Anti-Inflammatory Based Therapies
Natália Pessoa Rocha, Aline Silva de Miranda, Antônio Lúcio Teixeira
BioMed Research International (2015) Vol. 2015, pp. 1-12
Open Access | Times Cited: 191

Showing 1-25 of 191 citing articles:

Neuroinflammation in neurodegenerative disorders: the roles of microglia and astrocytes
Hyuk Sung Kwon, Seong‐Ho Koh
Translational Neurodegeneration (2020) Vol. 9, Iss. 1
Open Access | Times Cited: 1640
Neuroinflammation Induces Neurodegeneration.
Duraisamy Kempuraj, Ramasamy Thangavel, Prashant Natteru, et al.
PubMed (2016) Vol. 1, Iss. 1
Closed Access | Times Cited: 593
The gut-brain axis: is intestinal inflammation a silent driver of Parkinson’s disease pathogenesis?
Madelyn C. Houser, Malú G. Tansey
npj Parkinson s Disease (2017) Vol. 3, Iss. 1
Open Access | Times Cited: 475
The role of neuroimmune signaling in alcoholism
Fulton T. Crews, Colleen J. Lawrimore, T. Jordan Walter, et al.
Neuropharmacology (2017) Vol. 122, pp. 56-73
Open Access | Times Cited: 274
Natural Products from Cyanobacteria: Focus on Beneficial Activities
Justine Demay, Cécile Bernard, Anita Reinhardt, et al.
Marine Drugs (2019) Vol. 17, Iss. 6, pp. 320-320
Open Access | Times Cited: 252
Gut–Brain Axis: Role of Gut Microbiota on Neurological Disorders and How Probiotics/Prebiotics Beneficially Modulate Microbial and Immune Pathways to Improve Brain Functions
Suganya Kanmani, Byung‐Soo Koo
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 20, pp. 7551-7551
Open Access | Times Cited: 241
A C9ORF72/SMCR8-containing complex regulates ULK1 and plays a dual role in autophagy
Mei Yang, Liang Chen, Kunchithapadam Swaminathan, et al.
Science Advances (2016) Vol. 2, Iss. 9
Open Access | Times Cited: 224
Bioactive effects of quercetin in the central nervous system: Focusing on the mechanisms of actions
Natarajan Suganthy, Kasi Pandima Devi, Seyed Fazel Nabavi, et al.
Biomedicine & Pharmacotherapy (2016) Vol. 84, pp. 892-908
Closed Access | Times Cited: 213
Targeting the Microglial NLRP3 Inflammasome and Its Role in Parkinson's Disease
Md. Ezazul Haque, Mahbuba Akther, Md. Jakaria, et al.
Movement Disorders (2019) Vol. 35, Iss. 1, pp. 20-33
Closed Access | Times Cited: 205
Microglial-derived miRNA let-7 and HMGB1 contribute to ethanol-induced neurotoxicity via TLR7
Leon G. Coleman, Jian Zou, Fulton T. Crews
Journal of Neuroinflammation (2017) Vol. 14, Iss. 1
Open Access | Times Cited: 192
The NADPARK study: A randomized phase I trial of nicotinamide riboside supplementation in Parkinson’s disease
Brage Brakedal, Christian Dölle, Frank Riemer, et al.
Cell Metabolism (2022) Vol. 34, Iss. 3, pp. 396-407.e6
Open Access | Times Cited: 191
Neuropharmacological Effects of Quercetin: A Literature-Based Review
Md. Shahazul Islam, Cristina Quispe, Rajib Hossain, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 129
Gut dysbiosis, defective autophagy and altered immune responses in neurodegenerative diseases: Tales of a vicious cycle
Saravana Babu Chidambaram, Musthafa Mohamed Essa, Annan Gopinath Rathipriya, et al.
Pharmacology & Therapeutics (2021) Vol. 231, pp. 107988-107988
Open Access | Times Cited: 121
Kurarinone alleviated Parkinson's disease via stabilization of epoxyeicosatrienoic acids in animal model
Cheng‐Peng Sun, Junjun Zhou, Zhenlong Yu, et al.
Proceedings of the National Academy of Sciences (2022) Vol. 119, Iss. 9
Open Access | Times Cited: 81
NLRP3 expression in mesencephalic neurons and characterization of a rare NLRP3 polymorphism associated with decreased risk of Parkinson’s disease
Katharine M. von Herrmann, Lucas A. Salas, Eileen M. Martinez, et al.
npj Parkinson s Disease (2018) Vol. 4, Iss. 1
Open Access | Times Cited: 159
AMPK activation: Role in the signaling pathways of neuroinflammation and neurodegeneration
Christina Alves Peixoto, Wilma Helena de Oliveira, Shyrlene Meiry da Racho Araújo, et al.
Experimental Neurology (2017) Vol. 298, pp. 31-41
Closed Access | Times Cited: 158
Alpha-Synuclein: From Early Synaptic Dysfunction to Neurodegeneration
Veronica Ghiglieri, Valeria Calabrese, Paolo Calabresi
Frontiers in Neurology (2018) Vol. 9
Open Access | Times Cited: 141
Cerebrospinal fluid concentrations of inflammatory markers in Parkinson’s disease and atypical parkinsonian disorders
Sara Hall, Shorena Janelidze, Yulia Surova, et al.
Scientific Reports (2018) Vol. 8, Iss. 1
Open Access | Times Cited: 130
Blinded RT‐QuIC Analysis of α‐Synuclein Biomarker in Skin Tissue From Parkinson's Disease Patients
Sireesha Manne, Naveen Kondru, Huajun Jin, et al.
Movement Disorders (2020) Vol. 35, Iss. 12, pp. 2230-2239
Open Access | Times Cited: 116
N-Docosahexaenoylethanolamine ameliorates LPS-induced neuroinflammation via cAMP/PKA-dependent signaling
Taeyeop Park, Huazhen Chen, Karl Kevala, et al.
Journal of Neuroinflammation (2016) Vol. 13, Iss. 1
Open Access | Times Cited: 107
The Gut-Brain Axis in Neurodegenerative Diseases and Relevance of the Canine Model: A Review
Yoko M. Ambrosini, Dana C. Borcherding, Anumantha G. Kanthasamy, et al.
Frontiers in Aging Neuroscience (2019) Vol. 11
Open Access | Times Cited: 105
Oxidative stress and neuroinflammation in the story of Parkinson’s disease: Could targeting these pathways write a good ending?
Kambiz Hassanzadeh, Arman Rahimmi
Journal of Cellular Physiology (2018) Vol. 234, Iss. 1, pp. 23-32
Open Access | Times Cited: 103
Mitoapocynin Treatment Protects Against Neuroinflammation and Dopaminergic Neurodegeneration in a Preclinical Animal Model of Parkinson’s Disease
Anamitra Ghosh, Monica R. Langley, Dilshan S. Harischandra, et al.
Journal of Neuroimmune Pharmacology (2016) Vol. 11, Iss. 2, pp. 259-278
Open Access | Times Cited: 101
Aquaporin-4 mediates communication between astrocyte and microglia: Implications of neuroinflammation in experimental Parkinson’s disease
Hai‐Jian Sun, Rui Liang, Bang‐Hung Yang, et al.
Neuroscience (2016) Vol. 317, pp. 65-75
Closed Access | Times Cited: 96
Protein kinase Cδ upregulation in microglia drives neuroinflammatory responses and dopaminergic neurodegeneration in experimental models of Parkinson's disease
Richard D. Gordon, Neeraj Singh, Vivek Lawana, et al.
Neurobiology of Disease (2016) Vol. 93, pp. 96-114
Open Access | Times Cited: 89
Page 1 - Next Page

Scroll to top